Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
70.30
+2.40 (3.53%)
Apr 17, 2026, 4:00 PM EDT - Market closed
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $96.47 million as of April 20, 2026. Its market cap has increased by 697.17% in one year.
Market Cap
96.47M
Enterprise Value
48.30M
1-Year Change
697.17%
Ranking
Category
Stock Price
$70.30
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $96.47M, a decrease of -74.51%. That is a compound annual growth rate of -21.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 96.47M | 3.47% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 104.30M |
| ProMIS Neurosciences | 103.40M |
| Turn Therapeutics | 103.07M |
| Anixa Biosciences | 97.57M |
| Inovio Pharmaceuticals | 97.51M |
| Rani Therapeutics Holdings | 95.37M |
| Coeptis Therapeutics Holdings | 91.17M |
| PolyPid | 90.45M |